Ouellet Véronique, Zietarska Magdalena, Portelance Lise, Lafontaine Julie, Madore Jason, Puiffe Marie-Line, Arcand Suzanna L, Shen Zhen, Hébert Josée, Tonin Patricia N, Provencher Diane M, Mes-Masson Anne-Marie
Centre de recherche du Centre hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montreal, Canada.
BMC Cancer. 2008 May 28;8:152. doi: 10.1186/1471-2407-8-152.
Cell lines constitute a powerful model to study cancer, and here we describe three new epithelial ovarian cancer (EOC) cell lines derived from poorly differentiated serous solid tumors (TOV-1946, and TOV-2223G), as well as the matched ascites for one case (OV-1946).
In addition to growth parameters, the cell lines were characterized for anchorage independent growth, migration and invasion potential, ability to form spheroids and xenografts in SCID mice.
While all cell lines were capable of anchorage independent growth, only the TOV-1946 and OV-1946 cell lines were able to form spheroid and produce tumors. Profiling of keratins, p53 and Her2 protein expression was assessed by immunohistochemistry and western blot analyses. Somatic TP53 mutations were found in all cell lines, with TOV-1946 and OV-1946 harboring the same mutation, and none harbored the commonly observed somatic mutations in BRAF, KRAS or germline BRCA1/2 mutations found to recur in the French Canadian population. Conventional cytogenetics and spectral karyotype (SKY) analyses revealed complex karyotypes often observed in ovarian disease.
This is the first report of the establishment of matched EOC cell lines derived from both solid tumor and ascites of the same patient.
细胞系是研究癌症的有力模型,在此我们描述了三种新的上皮性卵巢癌(EOC)细胞系,它们源自低分化浆液性实体瘤(TOV - 1946和TOV - 2223G),以及一例患者的匹配腹水(OV - 1946)。
除生长参数外,还对这些细胞系进行了非锚定依赖性生长、迁移和侵袭潜能、形成球体的能力以及在SCID小鼠中形成异种移植物的特性分析。
虽然所有细胞系都能够进行非锚定依赖性生长,但只有TOV - 1946和OV - 1946细胞系能够形成球体并产生肿瘤。通过免疫组织化学和蛋白质印迹分析评估角蛋白、p53和Her2蛋白表达谱。在所有细胞系中均发现了体细胞TP53突变,TOV - 1946和OV - 1946具有相同的突变,且均未携带在法裔加拿大人群中常见的BRAF、KRAS体细胞突变或种系BRCA1/2突变。常规细胞遗传学和光谱核型分析(SKY)显示卵巢疾病中常见的复杂核型。
这是首次报道建立源自同一患者实体瘤和腹水的匹配EOC细胞系。